Berliner Institut für Gesundheitsforschung (BIH)

Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API) (2023) Speckmann C, Nennstiel U, Hoenig M, Albert MH, Ghosh S, Schuetz C, Brockow I, et al. Journal article Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations (2023) Wiesenfarth M, Gunther K, Muller K, Witzel S, Weiland U, Mayer K, Herrmann C, et al. Journal article Aberrant phase separation and nucleolar dysfunction in rare genetic diseases (2023) Mensah MA, Niskanen H, Magalhaes AP, Basu S, Kircher M, Sczakiel HL, Reiter AM, et al. Journal article A prospective survey study on the education and awareness about walking exercise amongst inpatients with symptomatic peripheral arterial disease in Germany (2023) Li Y, Rother U, Rosenberg Y, Hinterseher I, Uhl C, Mylonas S, Grambow E, et al. Journal article Daratumumab for the treatment of refractory ANCA-associated vasculitis (2023) Ostendorf L, Burns M, Wagner DL, Enghard P, Amann KU, Mei H, Eckardt KU, et al. Journal article Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma (2022) Welters C, Lammoglia Cobo MF, Stein CA, Hsu MT, Ben Hamza A, Penter L, Chen X, et al. Journal article C/EBPβ regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages (2022) Dörr D, Obermayer B, Weiner JM, Zimmermann K, Anania C, Wagner LK, Lyras EM, et al. Journal article Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization (2022) Wurster TH, Landmesser U, Abdelwahed YS, Skurk C, Morguet A, Leistner DM, Froehlich G, et al. Journal article Model soups improve performance of dermoscopic skin cancer classifiers (2022) Maron RC, Hekler A, Haggenmüller S, von Kalle C, Utikal JS, Müller V, Gaiser M, et al. Journal article Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial (2022) Goerling U, Gauler T, Dietz A, Grünwald V, Knipping S, Guntinas-Lichius O, Frickhofen N, et al. Journal article